BiphentinEffects in attention deficit hyperactivity disorder (ADHD) Drivers: a randomised, placebo controlled, crossover study of multilayer-release (MLR) methylphenidate on driving performance in adult ADHD patients.

Trial Profile

BiphentinEffects in attention deficit hyperactivity disorder (ADHD) Drivers: a randomised, placebo controlled, crossover study of multilayer-release (MLR) methylphenidate on driving performance in adult ADHD patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2010

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Acronyms BEAD
  • Sponsors Purdue Pharma
  • Most Recent Events

    • 01 Dec 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 14 Aug 2010 Planned end date (1 Dec 2010) added as reported by ISRCTN: Current Controlled Trials.
    • 14 Aug 2010 Status changed from completed to recruiting as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top